Hem › Inflammatorisk tarmsjukdom › Washington
Kliniska studier för Inflammatorisk tarmsjukdom i Washington
10 studier för Inflammatorisk tarmsjukdom söker deltagare vid platser i Washington.
Städer i Washington
Officiell studietext (engelska)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- University of Washington School Medicine, Seattle
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 30 sep. 2026 · NCT06598943A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 004, Seattle
- Site 019, Tacoma
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-021, Bellevue
- Site US-029, Tacoma
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT07845487Familial Inflammatory Bowel Disease Early Risk
- Seattle Children's Hospital, Seattle
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 0 till 55 · Alla kön · Uppdaterad 28 aug. 2026 · NCT07791862A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Seattle Children's Hospital, Seattle
RekryterarFas 3
Ålder 2 till 17 · Alla kön · Uppdaterad 24 aug. 2026 · NCT05509777Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Seattle Children's Hospital, Seattle
RekryterarFas 4
Ålder 6 till 17 · Alla kön · Uppdaterad 27 maj 2026 · NCT05781152Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
- Seattle Children's Hospital, Seattle
RekryterarObservationsstudie
Ålder 6 till 21 · Alla kön · Uppdaterad 24 apr. 2026 · NCT06315179A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Bellevue
- Mirador Therapeutics Selected Site, Silverdale
- Mirador Therapeutics Selected Site, Tacoma
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 12 mars 2026 · NCT07113522A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
- Liver institute Northwest, Seattle
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 24 okt. 2025 · NCT06699121Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
- Seattle Children's Hospital, Seattle
Rekryterar
Ålder 8 till 21 · Alla kön · Uppdaterad 12 juni 2025 · NCT06216899Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.